-
Mashup Score: 0Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence - 2 year(s) ago
Pancreatic cancer (PC) remains a highly lethal malignancy, and most patients with localized disease that undergo surgical resection still succumb to recurrent disease. Pattern of recurrence after pancreatectomy is heterogenous, with some studies illustrating that site of recurrence can be associated with prognosis.1 Another study suggested that tumors that develop local and distant recurrence can…
Source: GastroenterologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Gamuts – Radiology differential diagnosis - 2 year(s) ago
Gamuts: Comprehensive radiology differential diagnosis. Linking imaging findings to diseases and clinical images.
Source: gamuts.netCategories: Latest Headlines, RadiologyTweet-
Welcoming @TheDataSniffer @dkfchang @PierreEliasMD @Shimri17 -- our latest top followers! The Gamuts project provides knowledge to support #MachineLearning in #radiology: https://t.co/MPOpnDhwGf #AI #imagingAI
-
-
Mashup Score: 3Gamuts – Radiology differential diagnosis - 2 year(s) ago
Gamuts: Comprehensive radiology differential diagnosis. Linking imaging findings to diseases and clinical images.
Source: gamuts.netCategories: Latest Headlines, RadiologyTweet-
Welcoming @techcatgirl @DrSultanQahtani @TheDataSniffer @dkfchang -- our latest top followers! The Gamuts project provides knowledge to support #MachineLearning in #radiology: https://t.co/MPOpnDhwGf #AI #imagingAI
-
-
Mashup Score: 5Gamuts – Radiology differential diagnosis - 2 year(s) ago
Gamuts: Comprehensive radiology differential diagnosis. Linking imaging findings to diseases and clinical images.
Source: gamuts.netCategories: Latest Headlines, RadiologyTweet-
Welcoming @techcatgirl @DrSultanQahtani @dkfchang @Shimri17 -- our latest top followers! The Gamuts project provides knowledge to support #MachineLearning in #radiology: https://t.co/MPOpnDhwGf #AI #imagingAI
-
-
Mashup Score: 0Wolters Kluwer Health - 3 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Hem/Oncs, Latest HeadlinesTweet-
@NirajGusani @MPishvaian @EileenMOReilly @FlavioRochaMD @NbmerchantMD @DavendraSohal @SyedAAhmad5 @GIcancerDoc @mkatzmd @DrShubhamPant @drsmags @mnoel3232 @loconte @pashtoonkasi @DrKelseyKlute @doctorC369 @dkfchang @jordanberlin5 Agree! We have bio markers for a reason https://t.co/qamPZzOvBK
-
-
Mashup Score: 4
Our TNT experience in resected BR/LA PDAC revealed high negative margin rates despite low radiologic downstaging. Extended duration chemotherapy with associated biochemical and pathologic responses highly predicted postoperative survival. Potential modifications of initial chemotherapy treatment inc …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
@MPishvaian @EileenMOReilly @FlavioRochaMD @NbmerchantMD @NirajGusani @DavendraSohal @SyedAAhmad5 @mkatzmd @DrShubhamPant @drsmags @mnoel3232 @loconte @pashtoonkasi @DrKelseyKlute @doctorC369 @dkfchang @jordanberlin5 Supporting further the switch from @MayoCancerCare https://t.co/ZYHSoB0Acl
-
-
Mashup Score: 1
When patients do not respond to neoadjuvant FOLFIRINOX, early switch to GA should be considered. Future efforts should be directed toward identifying markers that will allow correct choice of initial therapy rather than attempting to rescue patients who respond poorly to first-line therapy.
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
@EileenMOReilly @FlavioRochaMD @NbmerchantMD @NirajGusani @DavendraSohal @SyedAAhmad5 @GIcancerDoc @mkatzmd @DrShubhamPant @drsmags @mnoel3232 @loconte @pashtoonkasi @DrKelseyKlute @doctorC369 @dkfchang @jordanberlin5 This is the "Switch" paper from MDACC https://t.co/FZlJFykR5N
-
-
Mashup Score: 12Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis - 3 year(s) ago
PURPOSE To analyze the prevalence of homologous recombination deficiency (HRD) in patients with pancreatic ductal adenocarcinoma (PDAC). MATERIALS AND METHODS We conducted a systematic review and meta-analysis of the prevalence of HRD in PDAC from PubMed, Scopus, and Cochrane Library databases, and online cancer genomic data sets. The main outcome was pooled prevalence of somatic and germline…
Source: Journal of Clinical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
HRD in #PancreaticCancer: comprehensive overview, prevalence meta-analysis, recommendations for clinical implementation https://t.co/yZaJwuSRXE #JCO #pancsm @Raffa_Casolino @pancreasverona @gimalleo @dkfchang https://t.co/3WUO7YSf6l
-
-
Mashup Score: 0Pan-cancer analysis of whole genomes - 4 year(s) ago
David Chang, MBBS, FRACS, PhD, University of Glasgow, Glasgow, UK, shares his views on the role of whole-genome analysis in…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Pan-cancer analysis of whole genomes w/ @dkfchang of @UofGlasgow: https://t.co/o5enhmohxR @VJOncology @myESMO @OncoAlert #ESMO20 #OncoAlert
-
-
Mashup Score: 0
David Chang, MBBS, FRACS, PhD, University of Glasgow, Glasgow, UK, outlines the PRECISION-Panc project, designed to bring together key stakeholders…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: PRECISION-Panc: platform to enhance biomarker discovery for #PancreaticCancer w/ @dkfchang of @UofGlasgow: https://t.co/WvJuFScve2 @VJOncology @myESMO @OncoAlert #ESMO20 @precisionpanc #Pancsm #OncoAlert
-
Most fascinated by data that absence of recurrence post resection in #PancreaticCancer correlated with RNF43 mutations. 2nd paper to show this after @nigeljamieson @dkfchang study in @AGA_Gastro. Rnf43 mutations create a favorable milieu impacting outcomes https://t.co/2wi6nflBRW